InDevR is a startup based in the United States. Brouky records 1 investor associated with the company.
InDevR develops multiplexed microarray-based analytical assays and platforms that accelerate the development, optimization, and manufacturing of various vaccine types including mRNA, protein-based, viral vector, polysaccharide, and conjugate vaccines.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.